Omrix Biopharmaceuticals Inc http://www.alacrastore.com/company-snapshot/Omrix_Biopharmaceuticals_Inc-3769338 Saturday, October 11, 2008 9:38:06 PM 3769338 Omrix Biopharmaceuticals Inc en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/ccbn/T1903619ccbn/T1903619norm...Ladies and gentlemen, thank you for standing by. Welcome to the Omrix second quarter #### financial results conference call. Before we begin, I'd like to remind you that this call contains forward-looking statements. Forward-looking statements provide the Company's current expectations or forecasts of future events. Forward-looking statements include statements about the Company's expectations, beliefs, plans, objectives, intentions, assumptions and other statements that are not historical facts. Forward-looking statements are subject to be known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by forward-looking statements. The Company's actual results could differ materially from those anticipated in forward-looking statements for many reasons including the factors described in the sections entitled risk factors and management discussions and analysts financial condition... 8/11/2008 11:06:00 PMOMRIX BIOPHARMACEUTICALS54.0000FinalOMRIX BIOPHARMACEUTICALS Q2 2008 Earnings Conference Call TranscriptOMRI4:30pm ETTranscriptT1903619Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/B1903619ccbn/B1903619norm...Co. reported #Q## total revenues of $##.#m and net income of $#m or $#.## per share on a diluted basis. ... 8/11/2008 9:06:00 PMOMRIX BIOPHARMACEUTICALS54.0000EditedOMRIX BIOPHARMACEUTICALS Q2 2008 Earnings Conference Call SummaryOMRI4:30pm ETBriefB1903619Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1825262ccbn/T1825262norm...Good day, ladies and gentlemen and welcome to the First Quarter #### Omrix Biopharmaceutical's Financial Results Conference Call. My name is Lacey and I'll be your coordinator for today. At this time all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of this conference. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded for replay purposes. I would now like to turn the presentation over to your host for today's call, Ms. Francesca DeMartino, Senior Director of Investor Relations. Please proceed. ... 5/12/2008 10:15:00 AMOMRIX BIOPHARMACEUTICALS54.0000FinalQ1 2008 OMRIX BIOPHARMACEUTICALS Earnings Conference Call TranscriptOMRI8:00am ETTranscriptT1825262Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1766062ccbn/T1766062norm...Welcome to OMRIX Fourth Quarter and Full-Year #### Financial Results Conference Call. Before we begin, I'd like to remind you that this call contains forward-looking statements. Forward-looking statements provide the Company's current expectations or forecasts of future events. Forward-looking statements include statements about the Company's expectations, beliefs, plans, objectives, intentions, assumptions, and other statements that are not historical facts. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statement. The Company's actual results could differ materially from those anticipated and forward-looking statements for many reasons, including the factors described in the sections entitled, Risk Factors and Management's Discussion and Analysis of Financial Condition and Results of Operations... 3/7/2008 12:05:00 PMOMRIX BIOPHARMACEUTICALS54.0000FinalQ4 2007 OMRIX BIOPHARMACEUTICALS Earnings Conference Call TranscriptOMRI11:00am ETTranscriptT1766062Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/srp/473191802srp/473191802norm...Address:### Fifth Avenue, ##nd Floor, New York, New York ##### Incorporated:DelawareWeb Site: www.omrix.comSIC Classification: Biological Products, Except Diagnostic Substances (####) Business Description: Omrix Biopharmaceuticals, Inc. is a commercial-stage company that aims to develop and market innovative biosurgical and passive immunotherapy products. The company aim is to develop novel technologies to provide safer and more effective options to patients in areas with substantial unmet medical needs. The company is utilizing their proprietary protein purification technology, innovative development capabilities, and manufacturing know-how to develop these product lines, often through collaborations with companies whose marketing and sales expertise are a complement to their own areas of specialty. Indices:Russell ####, Russell #### IPO Date: ##-##-####... 473191802681989109OMRI10/6/2006 12:15:00 PM473191802Credit & Investment ResearchSharkRepellent.net